XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Bitcoin Under Pressure as Trump Iran Strike Reports Emerge
Reports cited by CryptoPotato indicated that the Trump administration is reportedly preparing to authorize a strike on Iran, with a possible execution window of...
MSCI’s New Rules Put Strategy’s Index Eligibility at Risk
The adopted methodology introduces a five-ratio financial screen: any issuer that fails the initial core screen is deemed ineligible when it is flagged on four...
Visa Enables USDC Prefunding for Inyo Payout Clients
Visa is enabling eligible cross-border payout clients to prefund using USDC through Inyo, expanding the payments network’s stablecoin infrastructure for busines...
Taiwan Blocks Coinbase and Kalshi Before Local Vote: Report
Per the CryptoPotato report , users in Taiwan encountered access issues with both Coinbase, a major U. S.
Japan’s 3 Largest Banks Report Stablecoin Payment
Japan’s three largest banks have reported completing what they describe as the country’s first international crypto stablecoin payment, marking a rare instance...
Visa launches stablecoin payments via Visa Direct
Visa is adding stablecoin payment capability to Visa Direct, its real-time push-payments network, targeting near-instant global payouts for businesses and their...
